Head-to-head · WeighScore
BeyondMD vs Gimme Care
By GLP-1 ScorecardUpdated
Score comparison
Gimme Care has the higher recorded score — 84.6/100 to 66.8/100.
Gimme Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-value both-molecule pricing ($130/$163), verified, and nationwide.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | BeyondMD | Gimme Care |
|---|---|---|
| WeighScore | 66.8/100 | 84.6/100 |
| Grade | C | B |
| Site position | #198 | #15 |
| Semaglutide | Not verified (current medication-specific quote required) | $130/mo |
| Tirzepatide | Not verified (current medication-specific quote required) | $163/mo |
| Coverage | Advertises broad US coverage; confirm treatment and state availability | All 50 states |
| Brand-name access | Yes | Not confirmed |
| Oral / sublingual | Yes | Not confirmed |
Site position #198 · C
Strengths
- Injection and oral GLP-1 programs advertised
- Wegovy and Zepbound consultation routes listed
- Optional specialist and nutrition contacts described
What to consider
- Current medication-specific monthly prices not verified
- Consultation fees generally retained after clinical work starts, even if treatment is declined
- Medication refunds generally end at pharmacy processing
- Assigned practice, dispenser and treatment-specific state eligibility need confirmation
Site position #15 · B
Strengths
- $130 sema / $163 tirz
- All 50 states, LegitScript-verified
- Both molecules
What to consider
- Not the cheapest tier
- Injection-only
- Monitoring detail limited
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.